- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/10 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Patent holdings for IPC class C07D 401/10
Total number of patents in this class: 2809
10-year publication summary
|
216
|
214
|
224
|
217
|
169
|
149
|
143
|
139
|
113
|
18
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4795 |
87 |
| Merck Patent GmbH | 5729 |
67 |
| LG Chem, Ltd. | 17745 |
59 |
| Takeda Pharmaceutical Company Limited | 2713 |
56 |
| Novartis AG | 10463 |
54 |
| Merck Sharp & Dohme LLC | 3741 |
49 |
| Samsung Display Co., Ltd. | 37314 |
44 |
| F. Hoffmann-La Roche AG | 7878 |
37 |
| Boehringer Ingelheim International GmbH | 4576 |
35 |
| Gilead Sciences, Inc. | 2140 |
35 |
| Tosoh Corporation | 1355 |
35 |
| Janssen Pharmaceutica N.V. | 3304 |
32 |
| VALO Health, Inc. | 182 |
32 |
| Hodogaya Chemical Co., Ltd. | 433 |
29 |
| Hoffmann-La Roche Inc. | 3620 |
25 |
| Abbvie Inc. | 1828 |
24 |
| Novaled GmbH | 463 |
24 |
| Idemitsu Kosan Co., Ltd. | 4229 |
23 |
| Taisho Pharmaceutical Co., Ltd. | 863 |
22 |
| AstraZeneca AB | 2828 |
20 |
| Other owners | 2020 |